Department of Defense Awards Gupta Nearly $1M to Study Prostate Cancer Drug Resistance

Portrait of Sanjay Gupta, PhD, MS
Sanjay Gupta, PhD, MS

As part of their Idea Award program, the Department of Defense has awarded Sanjay Gupta, PhD, MS a total of $962,000 over three years to investigate drug resistance mechanisms in prostate cancer. The program aims to improve quality of life by decreasing the impact of cancer on active duty service members and their communities.

Gupta will use the award and clinically-approved drugs to develop a safe, efficacious and cost-effective combination therapy for castrate-resistant prostate cancer (CRPC). A member of the Case Comprehensive Cancer Center's GU Malignancies Program, Gupta is the Carter Kissell Professor and Research Director in the Department of Urology in the School of Medicine at Case Western Reserve University and University Hospitals Cleveland Medical Center. He is also a research scientist at the Louis Stokes VA Medical Center.

Gupta will be joined in the newly funded study by Gregory T. MacLennan, PhD, Matthew Cooney, MD, Pingfu Fu, PhD and Vinay Varadan, PhD, also members of the Case Comprehensive Cancer Center, along with Eswar Shankar, PhD, cancer biologist in the Department of Urology in the School of Medicine at Case Western Reserve.

More>